Overview and Usage
Brand name- Erlonat
Generics- Erlotinib Hydrochloride
Manufacturer- NATCO Pharma
Dosage form- Tablet
Route of Administration- oral
Strength- 100, 150mg
Composition- Erlotinib Hydrochloride
Packaging- bottle
Indication- non-small cell lung cancer (NSCLC) and pancreatic cancer.
Storage- Store at room temperature (10-30°C)
Class of drug- Kinase inhibitor
Mechanism Of Action
Erlonat 100 mg belongs to a class of medications called kinase inhibitors. It works by blocking the action of abnormal protein that signals cancer cells to multiply. This in turn helps to slow or inhibit the spread of cancer cells
Side Effects-
Rashes in the majority of patients.
Diarrhea, Loss of appetite, Fatigue, Partial Hair Loss.
Rarely, ingrown hairs, like eyelashes
Pharmacodynamics
It is the study of drug effects and what the medicine does to the body
It inhibits the intracellular phosphorylation of tyrosine kinase associated with epidermal growth factor (EGFR). The specificity of inhibition concerning other tyrosine kinase receptors has not been fully characterized. EGFR is also expressed on the cell surface of normal cells and cancer cells
Pharmacokinetics
Study of what the body does to the medicine. Erlonat is around 60% absorbed after administration into the body and its bioavailability is increased by food to almost 100%. Its half-life is 36 hours and it is cleared majorly by the CYP3A4 enzyme present in the body.
Minimum effect concentration (MEC)
A minimum concentration of medicine in the blood is required to produce the therapeutic effects. Its predefined therapeutic MEC is (0.8μg/ml)
Minimum toxic concentration (MTC)
Minimum concentration of medicine in blood above which toxic or adverse effects are precipitated. Its MTC is 1.25μg/ml
Bioavailability Rate
After oral administration, the medicine archived approximately 60% bioavailability, with administration with food enhancing bioavailability to upwards of 100%
Shelf Life
Shelf life is the period over which the concentration of the active medicinal ingredient in the formulation lowers by 10 percent from its value at the time of manufacture.
Its shelf life is 2years
Substitutes
- Tarceva
- Carac
Alternate Brands
- Erlocip by Cipla Ltd.
- Erlotib 150mg Tablet by Intas.
- Zyceva 150mg Tablet by Zydus.
- Erleva 100 mg/150 mg by Glenmark.
- Erlotirel 100 mg/150 mg by Reliance Life Sciences.


